Add-on Acquisition • Life Science

Solve Therapeutics Acquires Cereius

On June 22, 2023, Solve Therapeutics acquired life science company Cereius

Acquisition Context

This is Solve Therapeutics’ 1st transaction in the Life Science sector.
This is Solve Therapeutics’ 1st transaction in the United States.
This is Solve Therapeutics’ 1st transaction in North Carolina.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	June 22, 2023
Target	Cereius
Sector	Life Science
Buyer(s)	Solve Therapeutics
Deal Type	Add-on Acquisition

Target Company

Cereius

Durham, North Carolina, United States

Cereius a private company developing innovative next-generation, targeted radiodiagnostics and radiotherapeutics for cancer patients. Cereius is based in Durham, North Carolina.

Explore More Deals

Browse All 215,130 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Solve Therapeutics

San Diego, California, United States

Category	Company
Founded	2021
Sector	Life Science

DESCRIPTION

Solve Therapeutics is a biopharmaceutical company developing novel antibody-based therapeutics. Solve Therapeutics was founded in 2021 and is based in San Diego, California.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: North Carolina	1 of 1
Country: United States	1 of 1
Year: 2023	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - North Carolina M&A - United States M&A - 2023 M&A